Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes

@article{Taskinen2010AbilityOT,
  title={Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes},
  author={M. R. Taskinen and Philip J. Barter and Christian P Ehnholm and David R. Sullivan and Klaus Mann and John Simes and James D. Best and S. Hamwood and Anthony C Keech},
  journal={Diabetologia},
  year={2010},
  volume={53},
  pages={1846-1855}
}
The apolipoprotein B (ApoB):apolipoprotein A (ApoA)-I ratio may be a better indicator of cardiovascular disease (CVD) risk in people with type 2 diabetes than traditional lipid risk markers (LDL-cholesterol, HDL-cholesterol and triacylglycerol), but whether the ApoB:ApoA-I ratio should be used to indicate lipid-lowering therapy is still debated. The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study randomised 9,795 patients with type 2 diabetes to fenofibrate (200 mg daily… CONTINUE READING